Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

National opioid crisis

Abhimanyu Sud
CMAJ October 18, 2016 188 (15) 1107; DOI: https://doi.org/10.1503/cmaj.1150125
Abhimanyu Sud
Lecturer, Department of Family and Community Medicine; Director, Safe Opioid Prescribing Course, Continuing Professional Development, Faculty of Medicine, University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Friesen and colleagues1 have provided invaluable insight into unsafe opioid prescribing in Canada over a time when we have seen unprecedented increases in prescriptions for opioids2 and consequently the number of associated harms, including death.3

As an opioid prescribing educator, I agree with Lucyk and Nelson’s contention in their linked commentary4 that we require improved prescriber education. However, given the breadth of the crisis, our approach to unsafe prescribing needs to be far more comprehensive, rational and coordinated.

An excellent example of the disconnectedness of our current efforts comes from British Columbia and the decision of its regulatory college to set new standards for opioid prescribing for chronic noncancer pain based on the recently released guidelines from the Centers for Disease Control and Prevention.5 These new standards include what essentially amounts to a maximum dose of 90 MEQ (milligrams of morphine equivalent). Yet, as just one example, that province’s formulary still carries transdermal fentanyl in doses more than four times this maximum in the form of 100 μg fentanyl patches (400 MEQ).

We know that decisions about what is available on formulary influences prescribing practices.2,6 With multiple inconsistent factors influencing prescriber behaviour, how can we expect a consistent response from physicians? In no other area of medicine do we see, or would we tolerate, such divergence and inconsistency of prescribing practices.7

As we continue to recognize the lack of good evidence for the use of strong opioids in chronic noncancer pain (despite what Lucyk and Nelson claim about the effectiveness of fentanyl4) and the substantial harms associated with their use, it is time that policy-makers, regulators, educators, prescribers and the public come together to form a consistent, rational and safe approach to the use of these potent medications.

References

  1. ↵
    1. Friesen KJ,
    2. Woelk C,
    3. Bugden S
    . Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches. CMAJ 2016;188:648–53.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Gomes T,
    2. Mamdani MM,
    3. Paterson JM,
    4. et al
    . Trends in high-dose opioid prescribing in Canada. Can Fam Physician 2014;60:826–32.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Dhalla IA,
    2. Mamdani MM,
    3. Sivilotti ML,
    4. et al
    . Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009;181:891–6.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Lucyk S,
    2. Nelson L
    . Consequences of unsafe prescribing of transdermal fentanyl. CMAJ 2016;188:638–9.
    OpenUrlFREE Full Text
  5. ↵
    Professional standards and guidelines. Safe prescribing of drugs with potential for misuse/diversion. Vancouver: College of Physicians and Surgeons of British Columbia; 2016. Available: www.cpsbc.ca/files/pdf/PSG-Safe-Prescribing.pdf (accessed 2016 July 7).
  6. ↵
    1. Fischer B,
    2. Jones W,
    3. Murphy Y,
    4. et al
    . Recent developments in prescription opioid-related dispensing and harm indicators in Ontario, Canada. Pain Physician 2015;18:E659–62.
    OpenUrlPubMed
  7. ↵
    1. Dhalla IA,
    2. Mamdani MM,
    3. Gomes T,
    4. et al
    . Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario. Can Fam Physician 2011;57:e92–6.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 188 (15)
CMAJ
Vol. 188, Issue 15
18 Oct 2016
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
National opioid crisis
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
National opioid crisis
Abhimanyu Sud
CMAJ Oct 2016, 188 (15) 1107; DOI: 10.1503/cmaj.1150125

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
National opioid crisis
Abhimanyu Sud
CMAJ Oct 2016, 188 (15) 1107; DOI: 10.1503/cmaj.1150125
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • An expanded role for blood donor emerging pathogens surveillance
  • Beyond wastewater surveillance: refining environmental pathogen detection in the built environment
  • Observational evidence in support of screening for depression during pregnancy and the postpartum period
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire